
    
      The given pilot clinical trial of a medicinal product for medical use, is held to evaluate
      preliminary efficacy and safety/tolerability profiles of antroquinonol in adult patients with
      relapsed AML or at initial diagnosis when no intensive treatment is possible.
    
  